Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

FDA Questions Genasense's Efficacy Prior To ODAC Panel

Sep. 6, 2006

By Aaron Lorenzo

FDA examining guidance for emergency research

Sep. 6, 2006

By Aaron Lorenzo

FDA Questions Genasense's Efficacy Prior To ODAC Panel

Sep. 6, 2006

By Aaron Lorenzo

Auxilium, Oscient End Testim Pact; Auxilium Signing Lease

Sep. 6, 2006

By Aaron Lorenzo

Invitrogen Unveils Merger Plan For Sentigen: $25.9M In Cash

Sep. 5, 2006

By Aaron Lorenzo

FDA Examining Guidance For Emergency Research

Sep. 5, 2006

By Aaron Lorenzo

FDA Examining Guidance For Emergency Research

Sep. 5, 2006

By Aaron Lorenzo

Invitrogen Unveils Merger Plan For Sentigen: $25.9M In Cash

Sep. 5, 2006

By Aaron Lorenzo

Cerus Settles Class-Action Suit, Ends Headache For Management

Sep. 1, 2006

By Aaron Lorenzo

Cerus Settles Class-Action Suit, Ends Headache For Management

Sep. 1, 2006

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...